These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 6999984)
1. New in vitro kinetic model for evaluating bactericidal efficacy of antibiotics. Murakawa T; Sakamoto H; Hirose T; Nishida M Antimicrob Agents Chemother; 1980 Sep; 18(3):377-81. PubMed ID: 6999984 [TBL] [Abstract][Full Text] [Related]
2. Bactericidal activity of cefazolin, cefoxitin, and cefmetazole against Escherichia coli and Klebsiella pneumoniae. Goto S; Sakamoto H; Ogawa M; Tsuji A; Kuwahara S Chemotherapy; 1982; 28(1):18-25. PubMed ID: 7035088 [TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model. Odenholt I; Cars O J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293 [TBL] [Abstract][Full Text] [Related]
4. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Blaser J; Stone BB; Groner MC; Zinner SH Antimicrob Agents Chemother; 1987 Jul; 31(7):1054-60. PubMed ID: 3116917 [TBL] [Abstract][Full Text] [Related]
5. New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity. Grasso S; Meinardi G; de Carneri I; Tamassia V Antimicrob Agents Chemother; 1978 Apr; 13(4):570-6. PubMed ID: 352258 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755 [TBL] [Abstract][Full Text] [Related]
7. [Effect of inhibitory (MIC) and subinhibitory concentrations of tobramycin on bacteriostatic and bactericidal activities of beta-lactam antibiotics (author's transl)]. Masuda G; Yajima T; Nakamura K; Yanagishita T; Yamazaki E Jpn J Antibiot; 1979 Nov; 32(11):1189-95. PubMed ID: 117156 [No Abstract] [Full Text] [Related]
8. Study of Zhang W; Guo Y; Yang Y; Dong D; Zheng Y; Zhu D; Hu F Microb Drug Resist; 2020 Mar; 26(3):204-210. PubMed ID: 31553260 [No Abstract] [Full Text] [Related]
9. [Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)]. Shah PM; Stille W Arzneimittelforschung; 1978; 28(9):1539-41. PubMed ID: 383106 [TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of antimicrobial effect kinetics in an in vitro dynamic model. Firsov AA; Chernykh VM; Navashin SM Antimicrob Agents Chemother; 1990 Jul; 34(7):1312-7. PubMed ID: 2117416 [TBL] [Abstract][Full Text] [Related]
11. Correlation of predicted serum bactericidal activities and values measured in volunteers. Drusano G; Standiford H; Ryan P; McNamee W; Tatem B; Schimpff S Eur J Clin Microbiol; 1986 Feb; 5(1):88-92. PubMed ID: 3084247 [TBL] [Abstract][Full Text] [Related]
12. [In vitro comparative bactericidal effect of cefotaxime and cefixime in a kinetic model]. Rolin O; Roche G; Bouanchaud DH Presse Med; 1989 Oct; 18(32):1569-71. PubMed ID: 2530534 [TBL] [Abstract][Full Text] [Related]
13. In vitro bactericidal action of cephalosporins in different concentrations of serum. Magliulo E; Ceccarelli G; Bianchi PP; Piantieri G; Cafarelli A G Batteriol Virol Immunol; 1981; 74(1-6):39-47. PubMed ID: 6458527 [No Abstract] [Full Text] [Related]
14. [Bactericidal activity of aspoxicillin in an in vitro model simulating human serum levels]. Matsushita T; Kouyama K; Yamaguchi T Jpn J Antibiot; 1985 Jul; 38(7):1819-26. PubMed ID: 3906168 [TBL] [Abstract][Full Text] [Related]
15. Effect of two cancer chemotherapeutic agents on the antibacterial activity of three antimicrobial agents. Moody MR; Morris MJ; Young VM; Moyé LA; Schimpff SC; Wiernik PH Antimicrob Agents Chemother; 1978 Nov; 14(5):737-42. PubMed ID: 103494 [TBL] [Abstract][Full Text] [Related]
16. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay. Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643 [TBL] [Abstract][Full Text] [Related]
17. In-vitro anti-microbial susceptibility of clinical isolates of pathogenic bacteria to ten antibiotics including phosphomycin. Eke PI; Rotimi VO Afr J Med Med Sci; 1987 Mar; 16(1):1-8. PubMed ID: 3037870 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures. de Cueto M; López L; Hernández JR; Morillo C; Pascual A Antimicrob Agents Chemother; 2006 Jan; 50(1):368-70. PubMed ID: 16377714 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the bactericidal activity of moxifloxacin and levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae. Lemmen SW; Häfner H; Klik S; Lütticken R; Zolldann D Chemotherapy; 2003 May; 49(1-2):33-5. PubMed ID: 12714807 [TBL] [Abstract][Full Text] [Related]
20. In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections. Chen YT; Ahmad Murad K; Ng LS; Seah JT; Park JJ; Tan TY Ann Acad Med Singap; 2016 Jun; 45(6):245-50. PubMed ID: 27412057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]